16 May 2023 - 16 April 2024
Parkinson’s drug development through AI and massive compound screening
ZeClinics joins AseBio, Celtarys Research, and USC-Biofarma in a groundbreaking €147,000 project using AI and compound screening to develop new drugs for Parkinson's.